Parvovirus B19 infections

International Journal of Dermatology

Volumn 43, Issue 10, 2004, Pages 747-749

  Vafaie, Janet ^a   Schwartz, Robert A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; VIRUS ANTIBODY; VIRUS DNA;

ANEMIA; ARTHROPATHY; ARTICLE; BLOOD TRANSFUSION; BONE MARROW EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DOT HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA INFECTIOSUM; ERYTHROCYTE APLASIA; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPETENCE; INTRAUTERINE INFECTION; LABORATORY DIAGNOSIS; PARVOVIRUS; POLYMERASE CHAIN REACTION; PROGNOSIS; SERODIAGNOSIS; TREATMENT PLANNING;

ERYTHEMA INFECTIOSUM; HUMANS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN;

EID: 6444222074     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02413.x     Document Type: Article

References (20)

1. Katta R. Parvovirus B19: a review. Dermatol Clin 2002; 20: 1-13.
2. Sabella C, Goldfarb J. Parvovirus B19 infections. Am Fam Phys 1999; 60: 1455-1460.
3. Cossart YE, Cant B, Field AM. Parvovirus-like particles in human sera. Lancet 1975; 1: 72-73.
4. Cherry JD. Parvovirus infections in children and adults. Adv Pediatr 1999; 46: 245-269.
5. Anderson MJ, Cohen BJ. Human parvovirus B19 infections in the United Kingdom 1984-1986 [Letter]. Lancet 1987; 1: 738-739.
6. Chorba T, Coccia P, Holman RC, et al. The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). J Infect Dis 1986; 154: 383-393.
7. Gillespie SM, Carter ML, Asch S, et al. Occupational risk of human parvovirus B19 infections for school and day care personnel during an outbreak of erythema infectiosum. J Am Med Assoc 1990; 263: 2061-2065.
8. Feder HM, Anderson I. Fifth disease: a brief review of infections in childhood, in adulthood, and in pregnancy. Arch Intern Med 1989; 149: 2176-2178.
9. Harms M, Feldman R, Saurat JH. Papular-purpuric "gloves and socks" syndrome. J Am Acad Dermatol 1990; 23: 850-854.
10. Abuhammour W, Abdel-Haq N, Asmar B. Petechial eruption with parvovirus B19 infection. Arch Pediatr Adolesc Med 1999; 153: 87-88.
11. Ghigliotti G, Mazzarello G, Nigro A, et al. Papular-purpuric gloves and socks syndrome in HIV-positive patients. J Am Acad Dermatol 2000; 43: 916-917.
12. Zellman G. Erythema infectiosum (fifth disease). eMedicine Dermatology 2002. Available at: http://author.emedicine.com/derm/topic136.htm.
13. Xu J, Raff T, Muallem N, et al. Hydrops fetalis secondary to parvovirus B19 infections. J Am Board Fam Pract 2003; 16: 63-68.
14. Young N. Hematologic and hematopoietic consequences of B19 parvovirus infection. Semin Hematol 1988; 25: 159-172.
15. Serjeant GR, Topley JM, Mason K, et al. Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet 1981; 2 (8247): 595-597.
16. Kurtzman GJ, Ozawa K, Cohen B, et al. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 1987; 317: 287-294.
17. Cunningham D. Parvovirus B19 infection. eMedicine Dermatology 2002. Available at: http://author.emedicine.com/ped/topic192.htm.
18. Vafaie J, Schwartz RA. Erythema infectiosum. J Cutan Med Surg (in press).
19. Young NS. Parvovirus infection and its treatment. Clin Exp Immunol 1996; 104 (Suppl 1): 26-30.
20. Fairley CK, Smoleniec JS, Caul OF, et al. An observational study of effect of intrauterine transfusions on the outcome of fetal hydrops after parvovirus B19 infection. Lancet 1995; 346: 1335-1337.